Clinical trial
StaphVAX Immunogenicity and Safety in Orthopaedic Joint Surgery
NCT00211965 · Nabi Biopharmaceuticals, Industry · Completed
Key facts
| NCT number | NCT00211965 |
|---|---|
| Title | StaphVAX Immunogenicity and Safety in Orthopaedic Joint Surgery |
| Official title | A Multicenter, Randomized, Placebo-Controlled, Double-Blinded Study to Evaluate Safety and Immunogenicity of StaphVAX®, a Bivalent Staphylococcus Aureus Glycoconjugate Vaccine in Adult Patients Receiving an Orthopedic Prosthetic Implant |
| Lead sponsor | Nabi Biopharmaceuticals, Industry |
| Collaborators | Public Health England |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Staphylococcal Infections |
| Intervention type | Biological |
| Interventions | S. aureus Types 5 and 8 Capsular Polysaccharide Conjugate, placebo |
| Enrollment | 67 |
| Start date | Apr 1, 2005 |
| Primary completion | May 1, 2006 |
| Completion | Aug 1, 2006 |
| First posted | Sep 21, 2005 |
| Last update posted | Jan 4, 2008 |
| Countries | United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: